UPDATE: FDA Commissioner Scott Gottlieb to Deliver Keynote at RAPS Regulatory Convergence

US Food and Drug Administration (FDA) Commissioner Scott Gottlieb, MD, will address the global regulatory community on 11 September, delivering keynote remarks at the 2017 Regulatory Convergence conference at National Harbor on the DC Waterfront. The commissioner's keynote presentation was originally scheduled to take place during the opening plenary session, but is now scheduled as a lunchtime session on Monday, 11 September. The Convergence will take place 9–12 September at the Gaylord National Resort and Convention Center, National Harbor.

“Dr. Gottlieb has always been passionate and outspoken on public health policy, and we eagerly look forward to hearing directly from him on his vision for FDA and the overall direction of healthcare,” said RAPS Executive Director Paul Brooks. “RAPS is honored to have Dr. Gottlieb for one of his first large-scale public appearances as commissioner. I can’t think of a more fitting speaker to kick off our gathering of regulatory professionals from around the world.”

Gottlieb became the 23rd FDA commissioner in May. In his initial speech to agency staff, he called this “a time of great promise” for healthcare. Since taking over as head of FDA, he has identified addressing the national opioid addiction crisis, and increasing generic drug competition and speeding new generics to market as among his top priorities.

Gottlieb has an extensive resume, having worked in many prominent public health roles. He is a physician, medical policy expert and public health advocate who previously served as FDA’s deputy commissioner for medical and scientific affairs and before that, as a senior advisor to the commissioner. Prior to being sworn in as FDA commissioner, he was a resident fellow at the American Enterprise Institute and a clinical assistant professor at the New York University School of Medicine.